While these correlational in vivo results suggest that ALDH1A1 (not CD44) is the primary “driver” of ACC tumorigenesis, additional mechanistic and in vivo studies should be done to verify this hypothesis. Here, ALDH1A1 is linked to adrenal cortex carcinoma.